BioVaxys Technology Corp. Announces Revocation of Failure to File Cease Trade Order
VANCOUVER, BC, July 12, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) (the “Company“) is pleased to announce the revocation of the failure to file cease trade order (the “FFCTO“) issued by its principal regulator, the Ontario Securities Commission (the “OSC“), on May 15, 2024.
Related news for (BVAXF)
- BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update
- BioVaxys Technology Corp. Granted Management Cease Trade Order
- Exploring New Frontiers in Food Allergy Treatments: Market Set for $14B Growth
- Biovaxys Signs Binding Letter of Intent to Develop DPX™-Based Vaccines for Life Threatening Food Allergies
- BIOVAXYS ANNOUNCES PLANNED PRIVATE PLACEMENT AND DEBT SETTLEMENT